The Invesco Perpetual European Equity Fund aims to achieve capital growth in Continental Europe. The fund intends to invest primarily in shares in companies in Continental Europe, although it may include other European related investments.
Name | % Net Assets |
---|---|
Roche | 8.8% |
Novartis | 7.5% |
Koninklijke KPN | 4.0% |
TNT | 3.6% |
Zurich Financial Services | 3.2% |
Vivendi Universal | 3.2% |
Thales | 3.1% |
Carrefour | 3.0% |
Group 4 Securicor | 3.0% |
CRH | 2.9% |
Key | % Net Assets |
---|---|
Roche | 8.8% |
Novartis | 7.5% |
Koninklijke KPN | 4.0% |
TNT | 3.6% |
Other | 76.1% |
Date | 21-Nov-2024 |
---|---|
NAV | 177.62p |
Currency | GBP |
Change | -0.37p |
% | -0.21% |
YTD change | -16.08p |
YTD % | -8.30% |
Fund Inception | 18/01/1986 |
---|---|
Fund Manager | Jeffrey Taylor |
TER | 1.19 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | £20 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.18% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research